Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
I‐Ting Teng, Alexandra F. Nazzari, Misook Choe, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268767-e0268767
Open Access | Times Cited: 24

Showing 24 citing articles:

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 213
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4333-4346.e14
Open Access | Times Cited: 47
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates
Madhu Prabhakaran, Flávio Lemos Matassoli, David J. Leggat, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 14
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Shilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 11
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 10
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107915-107915
Open Access | Times Cited: 16
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
Noemia S. Lima, Maryam Musayev, Timothy S. Johnston, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct
Suruchi Singh, Yi Liu, Meghan C. Burke, et al.
Journal of Structural Biology X (2025) Vol. 11, pp. 100123-100123
Open Access
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection
Lela Kardava, James Lim, Clarisa M. Buckner, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115557-115557
Open Access
Fc-effector functional antibody assays for SARS-CoV-2 variants of concern
Xuemin Chen, Grace Li, Caroline Ciric, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Two-dimensional high-throughput on-cell screening of immunoglobulins against broad antigen repertoires
Yakov A. Lomakin, Leyla A. Ovchinnikova, Stanislav S. Terekhov, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Large-scale antibody immune response mapping of splenic B cells and bone marrow plasma cells in a transgenic mouse model
Xiaoli Pan, Sheila N. López Acevedo, Camille Cuziol, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates
Chaim A. Schramm, Damee Moon, Lowrey Peyton, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Designing structure and <i>E. coli</i> strain-producer bearing SARS-CoV-2 N, S, M, E protein-related sequence antigen
V. V. Kopat, A. A. Riabchenkova, E. L. Chirak, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 4, pp. 653-662
Open Access | Times Cited: 4
Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants
Jing Ma, Yongdong Huang, Guodong Jia, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137059-137059
Closed Access | Times Cited: 1
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
Matthew M. Hernandez, Radhika Banu, Paras Shrestha, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 6
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
Matheus Oliveira de Souza, Bharat Madan, I‐Ting Teng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response
Elliot Campbell, Julie Dobkin, Louis Osorio, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 832-832
Open Access | Times Cited: 2
A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response
Elliot Campbell, Julie Dobkin, Louis Osorio, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
Yongping Yang, Wing‐Pui Kong, Cuiping Liu, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1438-1438
Open Access | Times Cited: 1
Conversion of B.0 Lineage of Human Corona Virus (Covid-19) Into Notoriously Infecting Less Pathogenic and Immune Escape Omicron B.1.1.529.2.75.2 or BA.2.75.2 Variant
Asit Kumar Chakraborty
Journal of BioMed Research and Reports (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones
Noemia S. Lima, Maryam Musayev, Timothy S. Johnston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera
Mayo Yasugi, Yu Nakagama, Natsuko Kaku, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6248-6254
Open Access
A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
Matthew M. Hernandez, Radhika Banu, Paras Shrestha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top